Automating Fertility (REI) Specialty Drug Prior Auth

The Unique Challenges of Fertility Specialty Drug Prior Authorization

Fertility treatments frequently rely on high-cost specialty drugs, such as gonadotropins, GnRH antagonists/agonists, and progesterone, which are critical for successful IVF and IUI cycles. The prior authorization process for these medications is often complicated by variable payer policies, benefit-side determinations (medical vs. pharmacy), and the need for extensive clinical documentation specific to reproductive health. Missteps can lead to significant treatment delays, impacting patient care and outcomes.

Common Fertility Specialty Drugs Requiring Prior Auth

• Gonadotropins (e.g., FSH, LH) for ovarian stimulation
• GnRH agonists and antagonists to control ovulation
• Progesterone formulations for luteal phase support
• Recombinant human chorionic gonadotropin (hCG) for ovulation induction
• Specialty medications used in fertility preservation protocols

Klivira's Automated Workflow for Fertility Specialty Drug PA

Klivira streamlines the entire specialty drug PA workflow, from initial prescription to specialty pharmacy fulfillment, tailored for fertility practices. Our platform automates benefit-side determination, accurately identifying whether a fertility drug falls under the medical or pharmacy benefit for a given payer and patient. This prevents common misclassification errors that lead to delayed or denied authorizations.

Key Automation Features for Fertility PA

• **Automated Benefit-Side Determination:** Klivira's policy engine identifies the correct benefit path (medical vs. pharmacy) for each fertility drug, per payer, per patient context, preventing channel misdirection.
• **Multi-Channel Routing:** Pharmacy-benefit fertility drugs route through ePA partners like CoverMyMeds and Surescripts via NCPDP SCRIPT ePA, while medical-benefit drugs use X12 278, Da Vinci PAS, or payer portals.
• **Step-Therapy and Clinical Documentation Automation:** Klivira reads relevant medication history and treatment response data from FHIR MedicationRequest and Observation resources to fulfill step-therapy requirements common in fertility protocols.
• **Specialty Pharmacy Fulfillment Handoff:** For pharmacy-benefit fertility drugs, Klivira coordinates the post-approval fulfillment workflow with specialty pharmacy partners, improving time-to-medication.
• **Copay-Assistance Navigation:** The workflow identifies manufacturer copay-assistance program availability for high-cost fertility drugs and flags Medicare-patient exclusions, aiding patient financial navigation.

Seamless Integration with Fertility EMRs and Payer Systems

Klivira integrates directly with leading EMRs used in reproductive endocrinology clinics, leveraging SMART on FHIR capabilities to extract necessary clinical data such as medication orders, diagnostic results, and treatment plans. Our platform connects to diverse payer channels, including direct provider portals, X12 278 EDI, and Da Vinci PAS where available, ensuring comprehensive coverage for all fertility specialty drug submissions.

Standards Powering Efficient Fertility Specialty Drug PA

• **NCPDP SCRIPT:** The industry standard for pharmacy ePA, facilitating electronic submissions for patient-administered fertility medications.
• **FHIR MedicationRequest & Observation:** Utilized for extracting critical clinical data from EMRs for medical-benefit specialty drug PA and step-therapy documentation.
• **Da Vinci PAS:** Supports medical-benefit prior authorization submissions conforming to the Da Vinci Prior Authorization Support Implementation Guide.
• **X12 278:** The established EDI standard for medical-benefit prior authorization requests and responses.